chr8-17274932-A-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_152415.3(VPS37A):​c.616A>T​(p.Ile206Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0103 in 1,614,096 control chromosomes in the GnomAD database, including 114 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0079 ( 8 hom., cov: 32)
Exomes 𝑓: 0.011 ( 106 hom. )

Consequence

VPS37A
NM_152415.3 missense

Scores

4
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.10

Publications

10 publications found
Variant links:
Genes affected
VPS37A (HGNC:24928): (VPS37A subunit of ESCRT-I) This gene belongs to the VPS37 family, and encodes a component of the ESCRT-I (endosomal sorting complex required for transport I) protein complex, required for the sorting of ubiquitinated transmembrane proteins into internal vesicles of multivesicular bodies. Expression of this gene is downregulated in hepatocellular carcinoma, and mutations in this gene are associated with autosomal recessive spastic paraplegia-53. A related pseudogene has been identified on chromosome 5. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2012]
VPS37A Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 53
    Inheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00709638).
BP6
Variant 8-17274932-A-T is Benign according to our data. Variant chr8-17274932-A-T is described in ClinVar as Benign. ClinVar VariationId is 383980.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VPS37ANM_152415.3 linkc.616A>T p.Ile206Phe missense_variant Exon 5 of 12 ENST00000324849.9 NP_689628.2 Q8NEZ2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VPS37AENST00000324849.9 linkc.616A>T p.Ile206Phe missense_variant Exon 5 of 12 1 NM_152415.3 ENSP00000318629.4 Q8NEZ2-1

Frequencies

GnomAD3 genomes
AF:
0.00793
AC:
1206
AN:
152156
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00191
Gnomad AMI
AF:
0.0329
Gnomad AMR
AF:
0.0108
Gnomad ASJ
AF:
0.00836
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0103
Gnomad FIN
AF:
0.00640
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0112
Gnomad OTH
AF:
0.00862
GnomAD2 exomes
AF:
0.00836
AC:
2101
AN:
251350
AF XY:
0.00903
show subpopulations
Gnomad AFR exome
AF:
0.00160
Gnomad AMR exome
AF:
0.00596
Gnomad ASJ exome
AF:
0.00943
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00532
Gnomad NFE exome
AF:
0.0112
Gnomad OTH exome
AF:
0.0124
GnomAD4 exome
AF:
0.0105
AC:
15410
AN:
1461822
Hom.:
106
Cov.:
30
AF XY:
0.0105
AC XY:
7639
AN XY:
727212
show subpopulations
African (AFR)
AF:
0.00215
AC:
72
AN:
33480
American (AMR)
AF:
0.00695
AC:
311
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00930
AC:
243
AN:
26128
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39694
South Asian (SAS)
AF:
0.00974
AC:
840
AN:
86254
European-Finnish (FIN)
AF:
0.00577
AC:
308
AN:
53412
Middle Eastern (MID)
AF:
0.0153
AC:
88
AN:
5768
European-Non Finnish (NFE)
AF:
0.0116
AC:
12951
AN:
1111968
Other (OTH)
AF:
0.00984
AC:
594
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
793
1586
2378
3171
3964
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
492
984
1476
1968
2460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00793
AC:
1208
AN:
152274
Hom.:
8
Cov.:
32
AF XY:
0.00772
AC XY:
575
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.00190
AC:
79
AN:
41566
American (AMR)
AF:
0.0108
AC:
165
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00836
AC:
29
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.0108
AC:
52
AN:
4830
European-Finnish (FIN)
AF:
0.00640
AC:
68
AN:
10618
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0112
AC:
764
AN:
68000
Other (OTH)
AF:
0.00806
AC:
17
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
62
124
187
249
311
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00947
Hom.:
4
Bravo
AF:
0.00791
TwinsUK
AF:
0.0121
AC:
45
ALSPAC
AF:
0.0143
AC:
55
ESP6500AA
AF:
0.00250
AC:
11
ESP6500EA
AF:
0.0114
AC:
98
ExAC
AF:
0.00836
AC:
1015
Asia WGS
AF:
0.00289
AC:
10
AN:
3478
EpiCase
AF:
0.0113
EpiControl
AF:
0.0132

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

VPS37A: BP4, BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Jul 11, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Hereditary spastic paraplegia 53 Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia Benign:1
Dec 20, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
15
DANN
Benign
0.95
DEOGEN2
Benign
0.042
T;.
Eigen
Benign
-0.90
Eigen_PC
Benign
-0.83
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.94
D;D
MetaRNN
Benign
0.0071
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N;.
PhyloP100
2.1
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-1.1
N;N
REVEL
Benign
0.053
Sift
Uncertain
0.013
D;D
Sift4G
Uncertain
0.0050
D;D
Polyphen
0.034
B;B
Vest4
0.22
MVP
0.082
MPC
0.015
ClinPred
0.0059
T
GERP RS
0.28
Varity_R
0.067
gMVP
0.42
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17502618; hg19: chr8-17132441; API